Variant report
Variant | nsv4100 |
---|---|
Chromosome Location | chr3:164300753-164329023 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:6)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
(count:6 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-SERPINI1-9 | chr3:164326825-164326856 | XLOC_002900 |
2 | lnc-SERPINI1-9 | chr3:164326780-164326856 | XLOC_002900 |
3 | lnc-SI-3 | chr3:164326845-164326860 | XLOC_003312 |
4 | lnc-SERPINI1-9 | chr3:164326780-164326856 | XLOC_002900 |
5 | lnc-SERPINI1-9 | chr3:164326780-164326856 | XLOC_002900 |
6 | lnc-SERPINI1-9 | chr3:164326780-164326856 | XLOC_002900 |
No data |
No data |
Variant related genes | Relation type |
---|---|
QKI | miRNA target sites |
AKT1 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs141441121 | chr3:164301618-164301619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs150822520 | chr3:164301640-164301641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs139324447 | chr3:164301703-164301704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs552714639 | chr3:164301749-164301750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs150002160 | chr3:164301759-164301760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs76231191 | chr3:164301772-164301773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs73161524 | chr3:164325842-164325843 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs76426447 | chr3:164325857-164325858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs183004403 | chr3:164325864-164325865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs140688576 | chr3:164325911-164325912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188077026 | chr3:164325921-164325922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs560102858 | chr3:164325946-164325947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs576684303 | chr3:164325962-164325963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs145784827 | chr3:164325981-164325982 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs537659768 | chr3:164325991-164325992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs114246115 | chr3:164326062-164326063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs555858868 | chr3:164326085-164326086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs542143109 | chr3:164326105-164326106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs138495307 | chr3:164326114-164326115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs193056776 | chr3:164326160-164326161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs34226489 | chr3:164326176-164326177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs141992527 | chr3:164326220-164326221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs555824501 | chr3:164326221-164326222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs571097106 | chr3:164326256-164326257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs369432713 | chr3:164326257-164326258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs150514714 | chr3:164326373-164326374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs138361752 | chr3:164326374-164326375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs567267792 | chr3:164326378-164326379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs529845279 | chr3:164326383-164326384 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549598272 | chr3:164326387-164326388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs569700626 | chr3:164326399-164326400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs376406447 | chr3:164326401-164326402 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs149273307 | chr3:164326410-164326411 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs558676182 | chr3:164326458-164326459 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565676433 | chr3:164326466-164326467 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs534599245 | chr3:164326475-164326476 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs978542 | chr3:164326484-164326485 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs80116372 | chr3:164326485-164326486 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs542973303 | chr3:164326528-164326529 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs184612779 | chr3:164326636-164326637 | Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs139557406 | chr3:164326702-164326703 | Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs545282527 | chr3:164326716-164326717 | Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs189227558 | chr3:164326735-164326736 | Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs528038848 | chr3:164326942-164326943 | Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs555397370 | chr3:164326944-164326945 | Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs541725230 | chr3:164326956-164326957 | Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs560902911 | chr3:164326969-164326970 | Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs145267830 | chr3:164326984-164326985 | Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs549723988 | chr3:164327016-164327017 | Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs577991259 | chr3:164327036-164327037 | Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Bladder cancer | 21909424 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Cancer | 20164919 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:164301600-164301800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr3:164325800-164326600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr3:164326400-164326600 | Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
4 | chr3:164326400-164326800 | Active TSS | Brain Inferior Temporal Lobe | brain |
5 | chr3:164326600-164327000 | Active TSS | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr3:164326600-164327200 | Flanking Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr3:164326800-164327000 | Flanking Active TSS | Brain Inferior Temporal Lobe | brain |
8 | chr3:164327000-164331200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |